Literature DB >> 32730618

Integrated Drug Reviews at the US Food and Drug Administration.

Janet Woodcock1, Peter Stein2, Kevin Bugin3.   

Abstract

Mesh:

Substances:

Year:  2020        PMID: 32730618     DOI: 10.1001/jamainternmed.2020.1981

Source DB:  PubMed          Journal:  JAMA Intern Med        ISSN: 2168-6106            Impact factor:   21.873


× No keyword cloud information.
  2 in total

1.  New Drugs Regulatory Program Modernization: Vision, Strategic Objectives, and Impact.

Authors:  Kevin Bugin; Janet Woodcock; Peter Stein; Khushboo Sharma; Yonatan Tyberg
Journal:  Ther Innov Regul Sci       Date:  2020-10-26       Impact factor: 1.778

2.  Evaluating integration in collaborative cross-disciplinary FDA new drug reviews using an input-process-output model.

Authors:  Kevin Bugin; Gaetano R Lotrecchiano; Michael O'Rourke; Joan Butler
Journal:  J Clin Transl Sci       Date:  2021-09-30
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.